+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor



IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor



Jak-Stat 4(4): E1158379



Mice with genetically modified cardiac ryanodine receptor (Ryr2 (ADA/ADA) mice) are impaired in regulation by calmodulin, develop severe cardiac hypertrophy and die about 2 weeks after birth. We hypothesized that the interleukin 6 (IL-6)/signal transducer and activator of transcription-3 (STAT3) signaling pathway has a role in the development of the Ryr2 (ADA/ADA) cardiac hypertrophy phenotype, and determined cardiac function and protein levels of IL-6, phosphorylation levels of STAT3, and downstream targets c-Fos and c-Myc in wild-type and RyR2 (ADA/ADA) mice, mice with a disrupted IL-6 gene, and mice treated with STAT3 inhibitor NSC74859. IL-6 protein levels were increased at postnatal day 1 but not day 10, whereas pSTAT3-Tyr705/STAT3 ratio and c-Fos and c-Myc protein levels increased in hearts of 10-day but not 1-day old Ryr2 (ADA/ADA) mice compared with wild type. Both STAT3 and pSTAT3-Tyr705 accumulated in the nuclear fraction of 10-day old Ryr2 (ADA/ADA) mice compared with wild type. Ryr2 (ADA /ADA) /IL-6(-/-) mice lived 1.5 times longer, had decreased heart to body weight ratio, and reduced c-Fos and c-Myc protein levels. The STAT3 inhibitor NSC74859 prolonged life span by 1.3-fold, decreased heart to body weight ratio, increased cardiac performance, and decreased pSTAT-Tyr705/STAT3 ratio and IL-6, c-Fos and c-Myc protein levels of Ryr2 (ADA /ADA) mice. The results suggest that upregulation of IL-6 and STAT3 signaling contributes to cardiac hypertrophy and early death of mice with a dysfunctional ryanodine receptor. They further suggest that STAT3 inhibitors may be clinically useful agents in patients with altered Ca(2+) handling in the heart.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058031322

Download citation: RISBibTeXText

PMID: 27217982

DOI: 10.1080/21623996.2016.1158379


Related references

mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel. Journal of Receptor, Ligand and Channel Research 8: 43-51, 2015

Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. American Journal of Physiology. Heart and Circulatory Physiology 300(6): H2187-H2195, 2011

Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor. Plos One 9(8): E104338, 2015

Knock-down of the type 3 ryanodine receptor impairs sustained Ca2+ signaling via the T cell receptor/CD3 complex. Journal of Biological Chemistry 277(52): 50636-50642, 2002

Type 1 inositol (1,4,5)-trisphosphate receptor activates ryanodine receptor 1 to mediate calcium spark signaling in adult mammalian skeletal muscle. Journal of Biological Chemistry 288(4): 2103-2109, 2013

The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptor. Journal of Biological Chemistry 283(27): 18522-9, 2008

Intermolecular failure of L-type Ca2+ channel and ryanodine receptor signaling in hypertrophy. Plos Biology 5(2): E21, 2007

Involvement of ryanodine receptor type 3 in dopamine release from the striatum: evidence from mutant mice lacking this receptor. Biochemical and Biophysical Research Communications 266(2): 588-592, 1999

Peptide probe of ryanodine receptor function Imperatoxin A is a selective activator of skeletal-type ryanodine receptor isoforms. Biophysical Journal 70(2 PART 2): A123, 1996

A novel ryanodine receptor expressed in pancreatic islets by alternative splicing from type 2 ryanodine receptor gene. Biochemical and Biophysical Research Communications 397(2): 140-145, 2010

Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3. Pfluegers Archiv European Journal of Physiology 437(1): 43-48, 1998

Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes. Journal of Biological Chemistry 274(9): 5995-6002, 1999

Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice. Journal of Leukocyte Biology 85(3): 491-496, 2008